Expression vectors for C-terminal fusions with fluorescent proteins and epitope tags in Candida glabrata

Beese-Sims, 2012, Mutants in the Candida glabrata glycerol channels are sensitized to cell wall stress, Eukaryot. Cell, 11, 1512, 10.1128/EC.00231-12 Castano, 2003, Tn7-based genome-wide random insertional mutagenesis of Candida glabrata, Genome Res., 13, 905, 10.1101/gr.848203 Castano, 2005, Telomere length control and transcriptional regulation of subtelomeric adhesins in Candida glabrata, Mol. Microbiol., 55, 1246, 10.1111/j.1365-2958.2004.04465.x Cormack, 1999, Efficient homologous and illegitimate recombination in the opportunistic yeast pathogen Candida glabrata, Genetics, 151, 979, 10.1093/genetics/151.3.979 Cormack, 1999, An adhesin of the yeast pathogen Candida glabrata mediating adherence to human epithelial cells, Science, 285, 578, 10.1126/science.285.5427.578 Corzo-Leon, 2014, Surveillance of Candida spp. bloodstream infections: epidemiological trends and risk factors of death in two Mexican tertiary care hospitals, PLoS ONE, 9, e97325, 10.1371/journal.pone.0097325 Cuellar-Cruz, 2008, High resistance to oxidative stress in the fungal pathogen Candida glabrata is mediated by a single catalase, Cta1p, and is controlled by the transcription factors Yap1p, Skn7p, Msn2p, and Msn4p, Eukaryot. Cell, 7, 814, 10.1128/EC.00011-08 De Las Penas, 2003, Virulence-related surface glycoproteins in the yeast pathogen Candida glabrata are encoded in subtelomeric clusters and subject to RAP1- and SIR-dependent transcriptional silencing, Genes Dev., 17, 2245, 10.1101/gad.1121003 Dower, 1988, High efficiency transformation of E. coli by high voltage electroporation, Nucleic Acids Res., 16, 6127, 10.1093/nar/16.13.6127 Frieman, 2002, Modular domain structure in the Candida glabrata adhesin Epa1p, a beta1,6 glucan-cross-linked cell wall protein, Mol. Microbiol., 46, 479, 10.1046/j.1365-2958.2002.03166.x Goldstein, 1999, Three new dominant drug resistance cassettes for gene disruption in Saccharomyces cerevisiae, Yeast, 15, 1541, 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.0.CO;2-K Gudlaugsson, 2003, Attributable mortality of nosocomial candidemia, revisited, Clin. Infect. Dis., 37, 1172, 10.1086/378745 Horn, 2009, Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry, Clin. Infect. Dis., 48, 1695, 10.1086/599039 Iraqui, 2005, The Yak1p kinase controls expression of adhesins and biofilm formation in Candida glabrata in a Sir4p-dependent pathway, Mol. Microbiol., 55, 1259, 10.1111/j.1365-2958.2004.04475.x Kaur, 2004, Functional genomic analysis of fluconazole susceptibility in the pathogenic yeast Candida glabrata: roles of calcium signaling and mitochondria, Antimicrob. Agents Chemother., 48, 1600, 10.1128/AAC.48.5.1600-1613.2004 Kaur, 2005, A yeast by any other name: Candida glabrata and its interaction with the host, Curr. Opin. Microbiol., 8, 378, 10.1016/j.mib.2005.06.012 Lass-Florl, 2009, The changing face of epidemiology of invasive fungal disease in Europe, Mycoses, 52, 197, 10.1111/j.1439-0507.2009.01691.x Martinez-Jimenez, 2013, Sir3 Polymorphisms in Candida glabrata clinical isolates, Mycopathologia, 175, 207, 10.1007/s11046-013-9627-2 Nucci, 2013, Epidemiology of candidemia in Latin America: a laboratory-based survey, PLoS ONE, 8, e59373, 10.1371/journal.pone.0059373 Orta-Zavalza, 2013, Local silencing controls the oxidative stress response and the multidrug resistance in Candida glabrata, Mol. Microbiol., 88, 1135, 10.1111/mmi.12247 Pappas, 2003, A prospective observational study of candidemia: epidemiology, therapy, and influences on mortality in hospitalized adult and pediatric patients, Clin. Infect. Dis., 37, 634, 10.1086/376906 Pfaller, 2007, Epidemiology of invasive candidiasis: a persistent public health problem, Clin. Microbiol. Rev., 20, 133, 10.1128/CMR.00029-06 Pfaller, 2010, Epidemiology of invasive mycoses in North America, Crit. Rev. Microbiol., 36, 1, 10.3109/10408410903241444 Pfaller, 2012, Epidemiology and outcomes of candidemia in 3648 patients: data from the Prospective Antifungal Therapy (PATH Alliance(R)) registry, 2004–2008, Diagn. Microbiol. Infect. Dis., 74, 323, 10.1016/j.diagmicrobio.2012.10.003 Richardson, 2008, Changing epidemiology of systemic fungal infections, Clin. Microbiol. Infect., 14, 5, 10.1111/j.1469-0691.2008.01978.x Sikorski, 1989, A system of shuttle vectors and yeast host strains designed for efficient manipulation of DNA in Saccharomyces cerevisiae, Genetics, 122, 19, 10.1093/genetics/122.1.19 Tortorano, 2013, A 1-year prospective survey of candidemia in Italy and changing epidemiology over one decade, Infection, 41, 655, 10.1007/s15010-013-0455-6 Wach, 1997, Heterologous HIS3 marker and GFP reporter modules for PCR-targeting in Saccharomyces cerevisiae, Yeast, 13, 1065, 10.1002/(SICI)1097-0061(19970915)13:11<1065::AID-YEA159>3.0.CO;2-K Wisplinghoff, 2004, Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study, Clin. Infect. Dis., 39, 309, 10.1086/421946 Yapar, 2014, Epidemiology and risk factors for invasive candidiasis, Ther. Clin. Risk Manag., 10, 95, 10.2147/TCRM.S40160 Zilberberg, 2008, Secular trends in candidemia-related hospitalization in the United States, 2000–2005, Infect. Control Hosp. Epidemiol., 29, 978, 10.1086/591033 Zordan, 2013, Expression plasmids for use in Candida glabrata, G3, 1675